Scientific Programme - 15th Meeting of the EAU Section of Oncological Urology

View programme as: Grid view List view
Print: Print
Personal Planner

06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00

Main room
Foyer
Matterhorn
Zurich I & II
Hamburg

1. 06:00
2. 07:00
3. 08:00
4. 09:00
5. 10:00
6. 11:00
7. 12:00
8. 13:00
9. 14:00
10. 15:00
11. 16:00
12. 17:00
13. 18:00
14. 19:00
15. 20:00
16. 21:00
Main room
1. Welcome & opening address
  
  Welcome & opening address
  
  08:30 - 09:00
  Welcome & opening address
  
  Fri 26 January
  08:30 - 09:00
  
  Location:
  
  Main room
  
  08:30 - 08:40
  
  Welcome
  
  M. Brausi, Modena (IT)
  
  08:40 - 09:00
  
  Opening address The future of urology: The EAU perspective
  
  F.M.J. Debruyne, Arnhem (NL)
2. Prostate Cancer II: Locally advanced - Prostate cancer II
  
  Prostate cancer II Prostate Cancer II: Locally advanced
  
  08:30 - 11:30
  Prostate cancer II
  
  Prostate Cancer II: Locally advanced
  
  Sat 27 January
  08:30 - 11:30
  
  Location:
  
  Main room
  
  Moderators:
  
  A. Alcaraz, Barcelona (ES)
  S. Joniau, Leuven (BE)
  
  08:30 - 08:45
  
  Tools for detection of node metastasis: PSMA guided surgery
  
  T. Maurer, Munich (DE)
  
  08:45 - 09:40
  
  Management of loco-regional recurrence after definitive treatment
  
  08:45 - 09:00
  
  Cryoablation (+ video)
  
  B. Malavaud, Toulouse (FR)
  
  09:00 - 09:15
  
  Salvage radiation therapy
  
  A. Bossi, Villejuif (FR)
  
  09:15 - 09:30
  
  Salvage radical prostatectomy – Robotic (+ video)
  
  H.G. Van Der Poel, Amsterdam (NL)
  
  09:30 - 09:40
  
  Discussion
  
  09:40 - 10:20
  
  Debate Reappraisal of neoadjuvant therapy for high and very high-risk PCA
  
  09:40 - 09:55
  
  Yes - it does make sense
  
  A. Volpe, Novara (IT)
  
  09:55 - 10:10
  
  No - it is useless
  
  N. Mottet, Saint-Étienne (FR)
  
  10:10 - 10:20
  
  Discussion
  
  10:20 - 11:00
  
  Is lymph node dissection necessary in prostate cancer?
  
  10:20 - 10:35
  
  The American view
  
  C.P. Evans, Sacramento (US)
  
  10:35 - 10:50
  
  The European view
  
  M. Graefen, Hamburg (DE)
  
  10:50 - 11:00
  
  Discussion
  
  11:00 - 11:30
  
  Refreshment break
3. Prostate Cancer I - Prostate Cancer I: Diagnosis, pathology, screening, active surveillance
  
  Prostate Cancer I: Diagnosis, pathology, screening, active surveillance Prostate Cancer I
  
  09:00 - 13:10
  Prostate Cancer I: Diagnosis, pathology, screening, active surveillance
  
  Prostate Cancer I
  
  Fri 26 January
  09:00 - 13:10
  
  Location:
  
  Main room
  
  Chairs:
  
  M. Brausi, Modena (IT)
  F.M.J. Debruyne, Arnhem (NL)
  
  09:00 - 09:15
  
  Reflex testing with serum, urine and tissue biomarkers: Which, when and how viable?
  
  B. Djavan, Vienna (AT)
  
  09:15 - 09:20
  
  Questions
  
  09:20 - 09:35
  
  Genetic testing in inherited prostate cancer
  
  A. Alcaraz, Barcelona (ES)
  
  09:35 - 09:40
  
  Questions
  
  09:40 - 09:55
  
  Morphologic basis of mpMRI prostate cancer evaluation
  
  F. Algaba, Barcelona (ES)
  
  09:55 - 11:30
  
  MRI imaging targeted prostate biopsy: Comparing 3 different techniques. Is there really a difference in results?
  
  09:55 - 10:05
  
  Fusion biopsy (+ video)
  
  R. Sanchez-Salas, Paris (FR)
  
  10:05 - 10:15
  
  In-bore biopsy (+ video)
  
  J.P.M. Sedelaar, Nijmegen (NL)
  
  10:15 - 10:25
  
  Cognitive biopsy
  
  O. Rouviere, Lyon, Cedex (FR)
  
  10:25 - 10:45
  
  Discussion with clinical cases
  
  J. Barentsz, Nijmegen (NL)
  
  10:45 - 11:00
  
  MRI in men on active surveillance for prostate cancer: The PRECISE recommendations
  
  C. Moore, London (GB)
  
  11:00 - 11:15
  
  Biopsy or monitoring patients with negative MRI
  
  J. Hugosson, Gothenburg (SE)
  
  11:15 - 11:30
  
  Discussion
  
  11:30 - 12:00
  
  Refreshment break
  
  12:00 - 12:15
  
  How have recommendations against prostate cancer screening impacted the incidence and mortality of prostate cancer in the US
  
  C.P. Evans, Sacramento (US)
  
  12:15 - 12:25
  
  Discussion
  
  12:25 - 13:10
  
  Round table: Treatment modalities for intermediate risk prostate cancer: surgery vs hypofractionation RT vs focal therapy vs active surveillance
  
  Moderators :
  
  A. Villers, Lille (FR)
  
  J. Hugosson, Gothenburg (SE)
  
  12:25 - 12:33
  
  Surgery
  
  S. Joniau, Leuven (BE)
  
  12:33 - 12:41
  
  Hypofractionation RT
  
  C. Cozzarini, Milan (IT)
  
  12:41 - 12:49
  
  Focal therapy
  
  A. Villers, Lille (FR)
  
  12:49 - 12:57
  
  Active surveillance
  
  M. Roobol, Rotterdam (NL)
  
  12:57 - 13:10
  
  Discussion
4. Prostate cancer III - Advanced and metastatic disease
  
  Advanced and metastatic disease Prostate cancer III
  
  09:00 - 10:30
  Advanced and metastatic disease
  
  Prostate cancer III
  
  Sun 28 January
  09:00 - 10:30
  
  Location:
  
  Main room
  
  Moderators:
  
  To be confirmed
  H.G. Van Der Poel, Amsterdam (NL)
  
  09:00 - 09:15
  
  Open vs robotic surgery for locally advanced prostate cancer: Oncological and functional outcomes
  
  P. Gontero, Turin (IT)
  
  09:15 - 09:20
  
  Discussion
  
  09:20 - 10:00
  
  New trends for treatment of oligo metastatic prostate cancer
  
  09:20 - 09:30
  
  Radical prostatectomy
  
  M. Brausi, Modena (IT)
  
  09:30 - 09:40
  
  Radiotherapy
  
  B.A. Jereczek-Fossa, Milan (IT)
  
  09:40 - 09:50
  
  Chemo–hormone therapy
  
  N. Mottet, Saint-Étienne (FR)
  
  09:50 - 10:00
  
  Discussion
  
  10:00 - 10:30
  
  Salvage LND after radical prostatectomy for PSA recurrence: An up-date
  
  10:00 - 10:10
  
  Robotic (video)
  
  N. Suardi, Milan (IT)
  
  10:10 - 10:20
  
  Open (video)
  
  S. Joniau, Leuven (BE)
  
  10:20 - 10:30
  
  Discussion
  
  10:30 - 11:00
  
  Refreshment break
5. The best of uro-oncology in 2017 - The best of uro-oncology in 2017
  
  The best of uro-oncology in 2017 The best of uro-oncology in 2017
  
  11:00 - 12:00
  The best of uro-oncology in 2017
  
  The best of uro-oncology in 2017
  
  Sun 28 January
  11:00 - 12:00
  
  Location:
  
  Main room
  
  Moderators:
  
  A. Breda, Barcelona (ES)
  J.P.M. Sedelaar, Nijmegen (NL)
  
  11:00 - 11:15
  
  Prostate cancer
  
  P. Ghadjar, Berlin (DE)
  
  11:15 - 11:30
  
  Renal cancer
  
  E.E. Linares Espinós, Madrid (ES)
  
  11:30 - 11:45
  
  Urothelial cancer
  
  A. Noon, Sheffield (GB)
  
  11:45 - 12:00
  
  Testis and penile cancer
  
  M. Salagierski, Zielona Góra (PL)
6. Penile cancer
  
  Penile cancer
  
  11:30 - 12:20
  Penile cancer
  
  Sat 27 January
  11:30 - 12:20
  
  Location:
  
  Main room
  
  11:30 - 12:20
  
  Reducing treatment aggressiveness without impairing outcomes
  
  Moderators :
  
  B.E. Ayres, London (GB)
  
  D. Pfister, Cologne (DE)
  
  11:30 - 11:40
  
  Conservative surgery for penile cancer: Indications and techniques (+ video)
  
  S.S. Minhas, London (GB)
  
  11:40 - 11:45
  
  Discussion
  
  11:45 - 11:55
  
  From radical inguinal lymph node dissection to sentinel lymph node dissection for penile cancer
  
  B.E. Ayres, London (GB)
  
  11:55 - 12:00
  
  Discussion
  
  12:00 - 12:10
  
  Evolution of surgical techniques in testis cancer (+ video)
  
  D. Pfister, Cologne (DE)
  
  12:10 - 12:20
  
  Discussion
7. Locally advanced and metastatic - Renal cancer II
  
  Renal cancer II Locally advanced and metastatic
  
  12:00 - 13:30
  Renal cancer II
  
  Locally advanced and metastatic
  
  Sun 28 January
  12:00 - 13:30
  
  Location:
  
  Main room
  
  Moderators:
  
  S.D. Brookman-May, Munich (DE)
  O. Rodriguez Faba, Barcelona (ES)
  
  12:00 - 12:15
  
  The role of neoadjuvant and adjuvant therapy in kidney cancer
  
  A. Bamias, Athens (GR)
  
  12:15 - 12:20
  
  Discussion
  
  12:20 - 12:35
  
  Cytoreductive nephrectomy for metastatic RCC in the targeted therapy era
  
  V. Matveev, Moscow (RU)
  
  12:35 - 12:40
  
  Discussion
  
  12:40 - 12:55
  
  The revival of immunotherapy in RCC and novel clinical trials
  
  A. Necchi, Milan (IT)
  
  12:55 - 13:00
  
  Discussion
  
  13:00 - 13:30
  
  Clinical case discussion
  
  Moderator :
  
  A. Bamias, Athens (GR)
  
  Panel :
  
  A. Bex, Amsterdam (NL)
  
  E.E. Linares Espinós, Madrid (ES)
  
  V. Matveev, Moscow (RU)
  
  A. Necchi, Milan (IT)
  
  O. Rodriguez Faba, Barcelona (ES)
  
  13:30 - 13:35
  
  Closing remarks
8. Urothelial cancer II: Non muscle invasive bladder cancer
  
  Urothelial cancer II: Non muscle invasive bladder cancer
  
  12:20 - 14:10
  Urothelial cancer II: Non muscle invasive bladder cancer
  
  Sat 27 January
  12:20 - 14:10
  
  Location:
  
  Main room
  
  Moderators:
  
  J.W.F. Catto, Sheffield (GB)
  J. Palou, Barcelona (ES)
  
  12:20 - 12:30
  
  New techniques for bladder tumour resection: are they better than conventional TURBT?
  
  U. Nagele, Hall in Tirol (AT)
  
  12:30 - 12:35
  
  Discussion
  
  12:35 - 12:45
  
  Complications of TURBT
  
  A. Masson-Lecomte, Créteil (FR)
  
  12:45 - 12:50
  
  Discussion
  
  12:50 - 13:00
  
  Socio-economic impact of BCG shortage
  
  M. Colombel, Lyon (FR)
  
  13:00 - 13:05
  
  Discussion
  
  13:05 - 13:15
  
  Genomic classification of non muscle invasive bladder tumours
  
  J.W.F. Catto, Sheffield (GB)
  
  13:15 - 13:20
  
  Discussion
  
  13:20 - 13:30
  
  New diagnostic tools for upper urinary tract TCC
  
  A. Breda, Barcelona (ES)
  
  13:30 - 13:35
  
  Discussion
  
  13:35 - 14:10
  
  Panel discussion – Second opinion in difficult clinical cases
  
  Moderator :
  
  M. Babjuk, Prague (CZ)
  
  Panel :
  
  J.W.F. Catto, Sheffield (GB)
  
  M. Colombel, Lyon (FR)
  
  J. Palou, Barcelona (ES)
  
  E. Xylinas, Paris (FR)
9. Renal cancer I: Localised - Renal Cancer 1: Localised
  
  Renal Cancer 1: Localised Renal cancer I: Localised
  
  14:00 - 16:45
  Renal Cancer 1: Localised
  
  Renal cancer I: Localised
  
  Fri 26 January
  14:00 - 16:45
  
  Location:
  
  Main room
  
  14:00 - 15:05
  
  Alternative approaches for characterisation of renal tumours
  
  Moderators :
  
  P.L. Chlosta, Cracow (PL)
  
  A. Volpe, Novara (IT)
  
  14:00 - 14:10
  
  MRI
  
  J. Walz, Marseille (FR)
  
  14:10 - 14:20
  
  Conventional and optical renal mass biopsy
  
  T.M. De Reijke, Amsterdam (NL)
  
  14:20 - 14:30
  
  Liquid biopsy
  
  M. Freifrau von Brandenstein, ()
  
  14:30 - 14:45
  
  Discussion
  
  14:45 - 15:00
  
  The WHO ISUP classification of renal tumours: What has changed?
  
  G. Martignoni, Verona (IT)
  
  15:00 - 15:05
  
  Discussion
  
  -
  
  Treatment of renal cancer in the elderly (>75years)
  
  Moderators :
  
  H. Van Poppel, Leuven (BE)
  
  A. Minervini, Florence (IT)
  
  15:05 - 15:30
  
  Is partial nephrectomy always the best choice for T1b tumours?
  
  15:05 - 15:15
  
  Yes
  
  G. Janetschek, Salzburg (AT)
  
  15:15 - 15:25
  
  No
  
  M. Kuczyk, Hanover (DE)
  
  15:25 - 15:30
  
  Discussion
  
  15:30 - 16:00
  
  Debate Clamped vs. unclamped partial nephrectomy (Open, Lap. Robotic)
  
  15:30 - 15:40
  
  Clamped (+ video)
  
  P.L. Chlosta, Cracow (PL)
  
  15:40 - 15:50
  
  Unclamped (+ video)
  
  M. Gallucci, Rome (IT)
  
  15:50 - 16:00
  
  Discussion
  
  16:00 - 16:30
  
  Panel discussion of clinical cases: Localised RCC
  
  Moderator :
  
  P.F.A. Mulders, Nijmegen (NL)
  
  Panel :
  
  A. Breda, Barcelona (ES)
  
  G. Stewart, Cambridge (GB)
  
  H. Van Poppel, Leuven (BE)
  
  J. Walz, Marseille (FR)
  
  16:30 - 16:45
  
  Surveillance after nephrectomy: On the way towards evidence based protocols
  
  A. Bex, Amsterdam (NL)
  
  16:45 - 17:15
  
  Refreshment break
10. Controversial subjects on bladder cancer
  
  Controversial subjects on bladder cancer
  
  17:15 - 18:50
  Controversial subjects on bladder cancer
  
  Fri 26 January
  17:15 - 18:50
  
  Location:
  
  Main room
  
  Moderators:
  
  G.N. Thalmann, Berne (CH)
  E. Xylinas, Paris (FR)
  
  17:15 - 17:45
  
  The role of extended lymphadenectomy for bladder cancer
  
  17:15 - 17:25
  
  The American perspective
  
  C.P. Evans, Sacramento (US)
  
  17:25 - 17:35
  
  European perspective
  
  R.E. Hautmann, Neu-Ulm (DE)
  
  17:35 - 17:45
  
  Discussion
  
  17:45 - 18:10
  
  Robotic assisted radical cystectomy: Always the right urinary diversion?
  
  17:45 - 17:55
  
  No
  
  G.N. Thalmann, Berne (CH)
  
  17:55 - 18:05
  
  Yes
  
  H.G. Van Der Poel, Amsterdam (NL)
  
  18:05 - 18:10
  
  Discussion
  
  18:10 - 18:50
  
  Is there a role for local treatment in metastatic disease?
  
  18:10 - 18:20
  
  The urologist perspective
  
  A. Stenzl, Tübingen (DE)
  
  18:20 - 18:30
  
  The medical oncologist perspective
  
  A. Necchi, Milan (IT)
  
  18:30 - 18:40
  
  The radiation oncologist perspective
  
  To be confirmed
  
  18:40 - 18:50
  
  Discussion
Foyer
1. Lunch
  
  Lunch
  
  13:10 - 14:00
  Lunch
  
  Fri 26 January
  13:10 - 14:00
  
  Location:
  
  Foyer
Matterhorn
1. ESU Course - Kidney cancer
  
  Kidney cancer ESU Course
  
  14:30 - 17:30
  Kidney cancer
  
  ESU Course
  
  Sat 27 January
  14:30 - 17:30
  
  Location:
  
  Matterhorn
  
  Chair:
  
  J. Walz, Marseille (FR)
  
  14:30 - 14:35
  
  European School of Urology: a unique possibility for urological education
  
  J. Walz, Marseille (FR)
  
  14:35 - 14:40
  
  Introduction & aims
  
  J. Walz, Marseille (FR)
  
  14:40 - 15:00
  
  Diagnosis, biopsy and staging of kidney cancer
  
  J. Walz, Marseille (FR)
  
  15:00 - 15:15
  
  Management and treatment of kidney cancer
  
  15:00 - 15:15
  
  How to plan a surgical procedure and how to estimate surgical risk
  
  B.J. Challacombe, London (GB)
  
  15:15 - 16:05
  
  Videos on how I do it:
  
  15:15 - 15:25
  
  Radical nephrectomy
  
  A. Bex, Amsterdam (NL)
  
  15:25 - 15:35
  
  Partial nephrectomy
  
  B.J. Challacombe, London (GB)
  
  15:35 - 15:45
  
  Focal therapy
  
  J. Walz, Marseille (FR)
  
  15:45 - 15:55
  
  Active surveillance
  
  A. Minervini, Florence (IT)
  
  15:55 - 16:05
  
  Discussion
  
  16:05 - 16:20
  
  Refreshment break
  
  16:20 - 16:50
  
  Round table on how to avoid and manage complications : Bleeding, Prolonged ischemia, decreased renal function, urinary and vascular fistulae
  
  Panel :
  
  A. Bex, Amsterdam (NL)
  
  B.J. Challacombe, London (GB)
  
  A. Minervini, Florence (IT)
  
  J. Walz, Marseille (FR)
  
  16:50 - 17:05
  
  Factors influencing functional and oncological outcome of kidney cancer treatment
  
  A. Minervini, Florence (IT)
  
  17:05 - 17:25
  
  Medical treatment of kidney cancer: “Neoadjuvant” treatment of localised and advanced disease, Adjuvant treatment of kidney cancer, Treatment of metastatic disease
  
  A. Bex, Amsterdam (NL)
  
  17:25 - 17:30
  
  Discussion and close
Zurich I & II
1. STEPS Programme - STEPS (Session To Evaluate ProgresS) programme
  
  STEPS (Session To Evaluate ProgresS) programme STEPS Programme
  
  14:30 - 16:45
  STEPS (Session To Evaluate ProgresS) programme
  
  STEPS Programme
  
  Sat 27 January
  14:30 - 16:45
  
  Location:
  
  Zurich I & II
  
  Moderator:
  
  M. Brausi, Modena (IT)
  
  14:30 - 14:30
  
  Prostate cancer
  
  Moderator :
  
  C.P. Evans, Sacramento (US)
  
  14:30 - 14:30
  
  S. Joniau, Leuven (BE)
  
  14:30 - 14:30
  
  Bladder cancer
  
  Moderator :
  
  R.E. Hautmann, Neu-Ulm (DE)
  
  14:30 - 14:30
  
  M. Colombel, Lyon (FR)
  
  14:30 - 14:30
  
  Renal cancer
  
  Moderator :
  
  P.F.A. Mulders, Nijmegen (NL)
  
  14:30 - 14:30
  
  P.L. Chlosta, Cracow (PL)
  
  14:30 - 14:30
  
  Testis cancer
  
  Moderator :
  
  D. Pfister, Cologne (DE)
  
  14:30 - 14:30
  
  J.P.M. Sedelaar, Nijmegen (NL)
Hamburg
1. ESU HOT - ESU/ESUI Hands-on Training in prostate MRI reading for urologists
  
  ESU/ESUI Hands-on Training in prostate MRI reading for urologists ESU HOT
  
  14:30 - 18:00
  ESU/ESUI Hands-on Training in prostate MRI reading for urologists
  
  ESU HOT
  
  Sat 27 January
  14:30 - 18:00
  
  Location:
  
  Hamburg
  
  Chair:
  
  V. Kasivisvanathan, London (GB)
  
  14:30 - 14:40
  
  The importance of prostate MRI to the Urologist: Overview of the course
  
  V. Kasivisvanathan, London (GB)
  
  14:40 - 15:10
  
  Introduction to MRI sequences, scoring systems, PI-RADS
  
  J. Barentsz, Nijmegen (NL)
  
  15:10 - 15:35
  
  Interactive case discussion – reporting MRI using PI-RADS
  
  V. Panebianco, Rome (IT)
  
  15:35 - 15:45
  
  Treatment implications of an mpMRI-driven diagnostic pathway
  
  F. Sanguedolce, Barcelona (ES)
  
  15:45 - 15:50
  
  Introduction to the MIM software for MRI interpretation
  
  V. Kasivisvanathan, London (GB)
  
  15:50 - 16:35
  
  Assessment: Hand - on baseline assessment of MRI interpretation
  
  16:35 - 16:50
  
  Review of assessment scans
  
  J. Barentz, Nijmegen (NL)
  
  16:50 - 17:35
  
  Assessment: Hand -on baseline assessment of MRI interpretation
  
  17:35 - 17:50
  
  Review of assessment scans
  
  V. Panebianco, Rome (IT)
  
  17:50 - 18:00
  
  Close

ESOU18

Main room

Foyer

Matterhorn

Zurich I & II

Hamburg

Main room

Welcome & opening address

Prostate cancer II

Prostate Cancer I: Diagnosis, pathology, screening, active surveillance

Advanced and metastatic disease

The best of uro-oncology in 2017

Penile cancer

Renal cancer II

Urothelial cancer II: Non muscle invasive bladder cancer

Renal Cancer 1: Localised

Controversial subjects on bladder cancer

Foyer

Lunch

Matterhorn

Kidney cancer

Zurich I & II

STEPS (Session To Evaluate ProgresS) programme

Hamburg

ESU/ESUI Hands-on Training in prostate MRI reading for urologists

Print Your Selection